Sanofi shares rise as Dupixent shows benefits in smokers with lung disease and meets Phase 3 targets
JHVEPhoto Sanofi (NASDAQ:SNY) and Regeneron Pharmaceuticals' (NASDAQ: REGION) Dupixent met the primary endpoint and all key secondary endpoints of a ...
